Atlas Trials

Effects of Repeated Psilocybin Dosing in OCD

Clinical trial NCT05370911 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT05370911
Sponsor
Yale University
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 1
Study type
INTERVENTIONAL
Obsessive-Compulsive Disorder
Start date
2023-07-20
Primary completion
2026-02-17
Enrollment
28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.